Clinical support for decreased canonical signaling is found in the study by Schumann et al., who demonstrated decreased β-catenin levels in patients with DCM together with enhanced levels of the Wnt antagonists secreted frizzled-related protein (sFRP) −3 and sFRP47. This evidence concerns the gene FRZB and familial dilated cardiomyopathy.